These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4167045)

  • 1. Lupoid hepatitis: computer analysis defining "hepatitis" and "cirrhosis" phases and relationships between hepatocellular damage and immune reactions in the liver.
    Goldstein G; MacKay IR
    Australas Ann Med; 1967 Feb; 16(1):62-9. PubMed ID: 4167045
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative serologic, histologic and biochemical studies in liver cirrhosis].
    Denk H; Schnack H; Wiedermann G
    Wien Klin Wochenschr; 1969 Mar; 81(10):192-5. PubMed ID: 5783404
    [No Abstract]   [Full Text] [Related]  

  • 3. "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease.
    Soloway RD; Summerskill WH; Baggenstoss AH; Schoenfield LJ
    Gastroenterology; 1972 Sep; 63(3):458-65. PubMed ID: 4116064
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of chronic hepatitis. Correlation of clinical, biochemical and histological parameters in 32 cases.
    Gayotto LC; Strauss E; Alves VA; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):288-93. PubMed ID: 6200913
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.
    Korman MG; Hofmann AF; Summerskill WH
    N Engl J Med; 1974 Jun; 290(25):1399-402. PubMed ID: 4133590
    [No Abstract]   [Full Text] [Related]  

  • 6. Family with hepatitis-associated antigen. Spectrum of liver pathology.
    Bancroft WH; Warkel RL; Talbert AA; Russell PK
    JAMA; 1971 Sep; 217(13):1817-20. PubMed ID: 4999004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppresive treatment in chronic hepatitis and liver cirrhosis].
    Evers C; Hesch RD; Banzer D
    Med Welt; 1969 Feb; 8():415-21. PubMed ID: 4181608
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognosis of chronic persistent hepatitis.
    Becker MD; Baptista A; Scheuer PJ; Sherlock S
    Lancet; 1970 Jan; 1(7637):53-7. PubMed ID: 4188622
    [No Abstract]   [Full Text] [Related]  

  • 9. AN AUTOPSY CASE OF LUPOID HEPATITIS.
    OGAWA K; AKAGI T; TSUTSUMI A; OHTA Y
    Acta Pathol Jpn; 1964 Jan; 14():111-9. PubMed ID: 14196552
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic, virus-induced hepatitis].
    Fahrländer H; Huber F; Engelhart G
    Schweiz Med Wochenschr; 1968 Mar; 98(10):363-9. PubMed ID: 4173039
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic septal hepatitis.
    Gerber MA; Vernace S
    Virchows Arch A Pathol Anat Histol; 1974; 363(4):303-9. PubMed ID: 4138635
    [No Abstract]   [Full Text] [Related]  

  • 12. Australia antigen in chronic active liver disease with cirrhosis.
    Gitnick GL; Gleich GJ; Schoenfield LJ; Baggenstoss AH; Sutnick AI; Blumberg BS; London WT; Summerskill WH
    Lancet; 1969 Aug; 2(7615):285-8. PubMed ID: 4184209
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Normotest and Thrombotest, coagulation tests in hepatocellular disease.
    Hillenbrand P; Sherlock S
    Scand J Gastroenterol Suppl; 1973; 19():125-31. PubMed ID: 4123935
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical findings in patients with hepatitis and abnormal bile duct epithelium.
    Christoffersen P; Poulsen H; Winkler K
    Scand J Gastroenterol; 1970; 5(2):117-21. PubMed ID: 5429872
    [No Abstract]   [Full Text] [Related]  

  • 15. Granulomatous hepatitis of unknown etiology. An etiologic and functional evaluation.
    Guckian JC; Perry JE
    Am J Med; 1968 Feb; 44(2):207-15. PubMed ID: 5635675
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of serum complement levels in chronic liver disease.
    Finlayson ND; Krohn K; Fauconnet MH; Anderson KE
    Gastroenterology; 1972 Oct; 63(4):653-9. PubMed ID: 4116547
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.
    Cook GC; Mulligan R; Sherlock S
    Q J Med; 1971 Apr; 40(158):159-85. PubMed ID: 4933363
    [No Abstract]   [Full Text] [Related]  

  • 18. [The characteristics of the Waldenström form of chronic hepatitis (author's transl)].
    Buligesco L
    Acta Gastroenterol Belg; 1973; 36(4):249-59. PubMed ID: 4129264
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute viral hepatitis: factors possibly predicting chronic liver disease.
    Dietrichson O; Juhl E; Christoffersen P; Elling P; Faber V; Iversen K; Nielsen JO; Petersen P; Poulsen H
    Acta Pathol Microbiol Scand A; 1975 Jan; 83(1):183-8. PubMed ID: 47692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of chronic aggressive hepatitis with D-penicillamine].
    Lange J; Schumacher K; Witscher HP
    Dtsch Med Wochenschr; 1971 Jan; 96(4):139-45 passim. PubMed ID: 5539526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.